Identification of potential drug–drug interactions between antiretroviral drugs from prescriptions in the private health-care sector in South Africa
International Journal of STD & AIDS, 05/30/2012KatendeKyenda NL et al. –
These results demonstrate that potential DDIs were identified between ARVs mostly in three ARV combinations: Kaletra (lopinavir/ritonavir) and efavirenz, lopinavir/ritonavir and nevirapine and combinations of indinavir and ritonavir. There is a need for more education on the prescribing protocols for ARVs in the treatment of HIV–infected patients in the private health–care sector in South Africa.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.